- Report
- May 2025
- 185 Pages
Global
From €3987EUR$4,500USD£3,449GBP
- Report
- February 2025
- 184 Pages
Global
From €3987EUR$4,500USD£3,449GBP
- Report
- January 2025
- 185 Pages
Global
From €3987EUR$4,500USD£3,449GBP
- Drug Pipelines
- April 2025
- 280 Pages
Global
From €2658EUR$3,000USD£2,300GBP
- Report
- May 2025
- 114 Pages
Global
From €4208EUR$4,750USD£3,641GBP
- Drug Pipelines
- April 2025
- 204 Pages
Global
From €2658EUR$3,000USD£2,300GBP
- Report
- October 2024
- 200 Pages
Global
From €3322EUR$3,750USD£2,874GBP
- Report
- January 2025
- 146 Pages
Global
From €2800EUR$3,160USD£2,422GBP
€3500EUR$3,950USD£3,028GBP
- Report
- April 2025
- 150 Pages
Global
From €3411EUR$3,850USD£2,951GBP
€4297EUR$4,850USD£3,718GBP
- Report
- June 2025
- 400 Pages
Global
From €4385EUR$4,949USD£3,793GBP
- Report
- May 2025
- 133 Pages
Global
From €4297EUR$4,850USD£3,718GBP
- Report
- May 2025
- 138 Pages
Global
From €4297EUR$4,850USD£3,718GBP
- Report
- October 2024
- 134 Pages
North America
From €3544EUR$4,000USD£3,066GBP
- Report
- July 2023
- 205 Pages
Global
From €5226EUR$5,899USD£4,522GBP
- Report
- March 2023
- 174 Pages
Global
From €1682EUR$1,899USD£1,456GBP
- Report
- May 2022
- 467 Pages
Global
From €4252EUR$4,799USD£3,679GBP
- Report
- June 2022
- 322 Pages
Global
From €4252EUR$4,799USD£3,679GBP
- Report
- May 2022
- 199 Pages
Global
From €4252EUR$4,799USD£3,679GBP
- Report
- January 2022
- 176 Pages
Global
From €4252EUR$4,799USD£3,679GBP
- Report
- April 2024
- 76 Pages
Global
From €1240EUR$1,400USD£1,073GBP

The MicroRNA market is a subset of the genomics industry that focuses on the study of small, non-coding RNA molecules. MicroRNAs are involved in a variety of biological processes, including gene expression, development, and disease. They are increasingly being studied as potential therapeutic targets for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders.
The market for microRNA-based therapeutics is growing rapidly, driven by advances in sequencing technology and the development of new delivery systems. Companies are developing a variety of products, including diagnostics, therapeutics, and research tools.
Some of the major players in the microRNA market include Thermo Fisher Scientific, Illumina, Qiagen, Merck, and Novartis. Other companies, such as Exiqon, Bio-Rad, and Bio-Techne, are also active in the market. Show Less Read more